Autopsy report · NCT06672510
Safety and Effectiveness of the Akura Thrombectomy System for Use in the Removal of Emboli From the Pulmonary Arteries in Treating Acute Pulmonary Embolism (PE)
Cause of deathRegulatory or ethics
“Enrollment with the 12F device configuration is closed. Enrollment is temporarily halted pending regulatory authorization of a protocol amendment introducing a modified device configuration, after which enrollment is expected to resume.”
Life of this trial
- Registered 3 months before it started.
- Suspended: paused, and may or may not restart.
- 118 participants planned (an estimate, not an actual count).
Vital statistics
- Status
- Suspended
- Phase
- Na
- Sponsor
- Akura Medical
- Sponsor type
- Industry
- Conditions
- Pulmonary Embolism Acute
- Interventions
- ATC
- Participants
- 118 (planned, not actual)
- Sites
- 7
- Countries
- United States
Trials that died the same way
- PermeaDerm® vs. Mepilex-Ag® in Promoting Healing of Partial-thickness Burn Wounds
“Administratively closed prior enrollment of participants.” - Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery Disease
“Device superceded by next generation device. Enrollment stopped, long term follow up was completed in August of 2004.” - Dexmedetomidine Cycling and Sleep in the Pediatric ICU
“No enrollment, IRB closed” - Comparison of DSCT With IB-IVUS and Angiography in the Assessment of Coronary Artery Disease
“Subject recruitment was slow, so enrollment has been closed.” - Fampridine Pregnancy Exposure Registry
“Due to low enrollment, registration closed in agreement with the Regulatory Agency”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.